Experienced in Clear Cell Sarcoma

Monika K. Krzyzanowska

Toronto, ON, CA 
Experienced in Clear Cell Sarcoma
Toronto, ON, CA 
OverviewLocationsClinical Research

Overview

Monika Krzyzanowska practices in Toronto, Canada. Ms. Krzyzanowska is rated as an Experienced expert by MediFind in the treatment of Clear Cell Sarcoma. Her top areas of expertise are Anal Cancer, COVID-19, Febrile Neutropenia, and Thyroid Cancer.

Her clinical research consists of co-authoring 235 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Clear Cell Sarcoma.

Gender
Female

Locations

Toronto, ON, Canada
Other Locations
Toronto, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Multicenter, Randomized, Open-label, Phase 3 Trial Comparing Selpercatinib to Physicians Choice of Cabozantinib or Vandetanib in Patients With Progressive, Advanced, Kinase Inhibitor Naïve, RET-Mutant Medullary Thyroid Cancer (LIBRETTO-531)
A Multicenter, Randomized, Open-label, Phase 3 Trial Comparing Selpercatinib to Physicians Choice of Cabozantinib or Vandetanib in Patients With Progressive, Advanced, Kinase Inhibitor Naïve, RET-Mutant Medullary Thyroid Cancer (LIBRETTO-531)
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Selpercatinib, Cabozantinib, Vandetanib
Study Phase: Phase 3
A Investigator Initiated Phase II Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma
A Investigator Initiated Phase II Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma
Enrollment Status: Completed
Publish Date: October 17, 2024
Intervention Type: Drug
Study Drug: Sunitinib
Study Phase: Phase 2
Toward a Comprehensive Supportive Care Intervention for Older or Frail Men With mCRPC
Toward a Comprehensive Supportive Care Intervention for Older or Frail Men With mCRPC
Enrollment Status: Completed
Publish Date: May 18, 2022
Intervention Type: Other
A Multi-Centre, Randomized Controlled Trial of Self-Management and Activation to Reduce Treatment-Related Toxicities in Patients Receiving Adjuvant or First-Line Metastatic Oral or Systematic Therapy for Colorectal, Lymphoma or Lung Cancer (SMARTCare)
A Multi-Centre, Randomized Controlled Trial of Self-Management and Activation to Reduce Treatment-Related Toxicities in Patients Receiving Adjuvant or First-Line Metastatic Oral or Systematic Therapy for Colorectal, Lymphoma or Lung Cancer (SMARTCare)
Enrollment Status: Terminated
Publish Date: September 30, 2021
Intervention Type: Other
Study Phase: Not Applicable
View 3 Less Clinical Trials

235 Total Publications

Development of Machine Learning Systems to Predict Cancer-Related Symptoms With Validation Across a Health Care System.
Development of Machine Learning Systems to Predict Cancer-Related Symptoms With Validation Across a Health Care System.
Journal: JCO clinical cancer informatics
Published: September 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Krzyzanowska's expertise for a condition
ConditionClose
    View All 21 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile